Camden National Corporation’s Amgen AMGN Stock Holding History

Camden National Corporation’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$299K	Buy	+1,202	New	+$287K	0.06%	120

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Camden National Corporation's AMGN Position: Q1 2021 in Review

Camden National Corporation opened a new position in Amgen (AMGN) in Q1 2021: 1,202 shares worth $299K. The stake represents 0.06% of the portfolio and ranks #120 among its holdings.

2,218 funds tracked by Wall St. Rank hold AMGN as of Q1 2021.

Camden National Corporation held 1,202 shares of Amgen worth $299K as of Q1 2021.
Amgen was a new Camden National Corporation position in Q1 2021.
Amgen made up 0.06% of Camden National Corporation's portfolio in Q1 2021, its #120 holding.
2,218 funds tracked by Wall St. Rank held Amgen as of Q1 2021.

Based on Camden National Corporation's 13F filing for Q1 2021, filed 12 May 2021.